AME Logo
RE

Richard Elion

MD

Washington Health Institute, United States

Biography

Richard Elion is currently the director of clinical research at Washington Health Institute and a Clinical Professor of Medicine at George Washington University School of Medicine. He also works at the District of Columbia Department of Health in the sexual health program and is on a city-wide initiative on HIV prevention. Dr. Elion also chairs the HIV division of Trio Health, a technology company that analyzes large retrospective cohorts of PLWH around the US. Previously he had worked at Whitman-Walker Health from 2016 to 2006 as Clinical Research Director. He has been active in HIV care and research for 28 years, Dr. Elion’s tenure at Whitman-Walker has coincided with the organization being selected in 2013 as part of the AIDS Clinical Trials Group by the National Institutes of Health (NIH), a distinguished honor for Whitman-Walker, and rare for a community health center.

Prior to joining Whitman-Walker Health, Dr. Elion served as co-director of HIV services at Washington Free Clinic, in private practice in Washington, D.C., and in various research and clinical capacities in New York and in Washington.

Dr. Elion received a bachelor’s degree in English and Psychobiology from Tufts University and a medical degree from Temple University. He completed his internship and residency at Duke University. He also holds a Master’s in Counselling and Spiritual Psychology from the University of Santa Monica.

RELATED COURSES

CME Series | Long-Acting Anti-Infectives
HIV
COVID-19
RSV
Tuberculosis
Viral Hepatitis and Liver Disease
60 min
Richard Elion, Natella Rakhmanina, François Venter

CME Series | Long-Acting Anti-Infectives

This module focuses on the evolving landscape of long-acting anti-infective therapies, emphasizing recent advances in HIV prevention and treatment. Participants will explore current approved drugs and promising therapies in development, with a special focus on pediatric and adolescent populations. The module also addresses the challenges and opportunities for implementing long-acting antiretrovirals in resource-limited settings.

What Will Set You Apart?

By completing this module, you will:

  • Understand current and emerging long-acting drugs and therapies for HIV prevention
  • Evaluate the progress and challenges in developing long-acting anti-infective options for children and adolescents
  • Discuss the implementation of long-acting antiretroviral therapies in resource-limited settings

Is This Program for You?

This module is designed for clinicians, researchers, program managers, and public health professionals involved in HIV prevention and treatment. It is particularly relevant for those focused on pediatric and adolescent care, as well as those working in resource-limited environments where innovative therapeutic options are critical.

What Will You Cover in This Module?

  • Current and Future Perspectives in HIV Prevention
  • The Long-Acting Anti-Infective Agents for Children and Adolescents
  • Long-Acting Anti-Infectives in Resource-Limited Settings